Filter Results

Clinical Studies

Closed for Enrollment

  • Cardiovascular Disease Specimen Repository Rochester, Minn.

    The purpose of the study is collect specimens for future studies to identify markers circulating in the blood that are associated with the development of further complications of heart disease.

  • Heart Failure in the Community Rochester, Minn.

    The purpose of this study is to characterize the contribution of isolated diastolic heart failure to heart failure using active surveillance to measure the plasma levels of brain natriuretic peptide (BNP) among persons with heart failure and to define the prognostic value of BNP in all cases of heart failure.

  • Right Drug, Right Dose, Right Time – Using Genomic Data to Individualize Treatment (The RIGHT Protocol) Rochester, Minn.

    This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of patients.

    This study is asking to allow access to stored blood sample in the Mayo Clinic Biobank (IRB#08-007049) so researchers can study DNA to find out if genetic variants that play a role in how the body responds to certain drugs, primarily prescription drugs. In this study, we are interested in genetic variants that may affect whether some people:

    • need a lower or higher dose of a drug

    • are at an increased risk of side effects to a drug

    • should avoid certain drugs

    By doing this study, we are developing and improving ways to incorporate information about drug related genetic variants into the medical record. Some information about your genetic variants will be put into your medical record to guide your clinical care. Furthermore, we hope to identify new genetic variants related to how people’s bodies respond to drugs.